Results 111 to 120 of about 4,028 (176)

Mobile Health (mHealth) for Chronic Low Back Pain Assessment: Design, Development, and Usability Evaluation. [PDF]

JOR Spine
Alfikri ZF, Johnson ME, Dicianno BE, Greco CM, Parmanto B, Piva SR, Roos RE, Saptono A, Sowa GA, Zhou L, Bell KM.   +10 more
europepmc   +1 more source

Generative listening leading to generative action to enhance interdisciplinary connections in a specialized referral hospital setting. [PDF]

Clinics (Sao Paulo)
Mansur AJ, Freitas Filho O, Albuquerque CP, Mello BF, Letaif LSH, Utiyama EM.   +5 more
europepmc   +1 more source

Exploring how surface treatments affect the bond stability of lithium disilicate ceramic to resin cement during try-in. [PDF]

Braz Dent J
Pilecco RO, Machry RV, Piva AMOD, Tribst JPM, Kleverlaan CJ, Moraes RR, Pereira GKR.   +6 more
europepmc   +1 more source

In-Field Ecological Momentary Assessment From Wearable Motion Sensors and Self-Report in a Chronic Low Back Pain Cohort. [PDF]

JOR Spine
Bell KM, Alfikri Z, Anderst W, Clark WW, Cook HA, Darwin J, Dicianno BE, Greco CM, Hoydick J, Jakicic JM, McKernan GP, Parmanto B, Patterson CG, Piva SR, Roos RE, Schneider MJ, Sundaram M, Vo NV, Zhou L, Sowa GA.   +19 more
europepmc   +1 more source

Development and reliability of a systematic method to evaluate lumbar paraspinal muscle size and quality in computed tomography images. [PDF]

N Am Spine Soc J
Carlesso CR, Sions JM, Anderst WJ, Patterson CG, Barbosa RM, Weissmann LP, Gale T, Schneider MJ, Piva SR.   +8 more
europepmc   +1 more source

Microplastics as both a driver of genitourinary cancers and a deliverer of treatments. [PDF]

Commun Med (Lond)
Sridharan K, Maiorano BA, Rehan F, Maradonna F, Giorgini E, Taha T, Molina-Cerrillo J, Buti S, Piva F, Massari F, Santoni M.   +10 more
europepmc   +1 more source

Alquimista, chamán, beatnik... Roberto Piva

La Colmena, 2016
Gladys Mendía
doaj  

Identification of a capsid-derived Zika virus epitope with high IgG discriminatory performance. [PDF]

Arch Virol
Dos Santos ALC, Lopes SR, Amaral RP, Malaquias LCC, Dos Santos Nunes Ferreira A, de Oliveira DB, Coelho LFL.   +6 more
europepmc   +1 more source

MDM2 Drives Proteasome Inhibitor Resistance and Represents a TP53-Independent Therapeutic Vulnerability in Multiple Myeloma. [PDF]

Cells
Labrador M, Cozzubbo S, Porro M, Cumerlato M, Bandini C, Mereu E, Paradzik T, Donati B, Manicardi V, Ronchetti D, D'Agostino M, Larocca A, Gay F, Bruno B, Ciarrocchi A, Chatr-Aryamontri A, Neri A, Morelli E, Piva R.   +18 more
europepmc   +1 more source